Alphatec Holdings (ATEC) Change in Account Payables (2010 - 2026)
Alphatec Holdings (ATEC) reported Change in Account Payables of $201000.0 for Q1 2026, up 101.69% on a YoY basis from $99659.6 in Q1 2025, and down 96.12% sequentially from $5.2 million in Q4 2025.
Alphatec Holdings (ATEC) Change in Account Payables (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Change in Account Payables data on file, last reported at $201000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 101.69% year-over-year to $201000.0; the trailing twelve-month figure through Mar 2026 stood at $963000.0 (up 110.67% YoY), and the FY2025 full-year result was -$11.2 million, down 215.36% from the prior year.
- Change in Account Payables eased to $201000.0 in Q1 2026, from $5.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $15.4 million in Q2 2024 to a low of -$14.7 million in Q3 2025.
- A 5-year average of $911823.5 and a median of $201000.0 in 2026 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 32071.43% in 2023 and tumbled 17976.47% in 2024, its largest moves.
- Tracing ATEC's Change in Account Payables over 5 years: stood at $2.4 million in 2022, then tumbled by 239.93% to -$3.3 million in 2023, then plunged by 92.21% to -$6.3 million in 2024, then jumped by 181.67% to $5.2 million in 2025, then tumbled by 96.12% to $201000.0 in 2026.
- Business Quant data shows ATEC's Change in Account Payables at $201000.0 in Q1 2026, $5.2 million in Q4 2025, and -$14.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 201,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | 5.18 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Sep 30, 2025 | -14.69 Mn |
| Sep 30, 2025 | -14.69 Mn |
| Jun 30, 2025 | 10.27 Mn |
| Jun 30, 2025 | 10.27 Mn |
| Mar 31, 2025 | -11.92 Mn |
| Mar 31, 2025 | -11.92 Mn |
| Dec 31, 2024 | -6.35 Mn |
| Dec 31, 2024 | -6.35 Mn |
| Sep 30, 2024 | -6.15 Mn |
| Sep 30, 2024 | -6.15 Mn |
| Jun 30, 2024 | 15.38 Mn |
| Jun 30, 2024 | 15.38 Mn |
| Mar 31, 2024 | 6.78 Mn |
| Mar 31, 2024 | 6.78 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |